Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Schechter

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancer|January 15, 1982
Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancerE C Bradley, G P Schechter, M J Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosisE Dmitrovsky, M J Matthews, P A Bunn, et al.
Annals of Internal Medicine|February 1, 1983
The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemiaD W Blayney, E S Jaffe, R I Fisher, et al.
The New England Journal of Medicine|August 4, 1983
Clinical course of retrovirus-associated adult T-cell lymphoma in the United StatesP A Bunn, G P Schechter, E Jaffe, et al.
Annals of Internal Medicine|September 1, 1988
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groupsE A Sausville, J L Eddy, R W Makuch, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
The New England Journal of Medicine|December 28, 1989
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoidesF J Kaye, P A Bunn, S M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-upC F Winkler, E A Sausville, D C Ihde, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancer|January 15, 1982
Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancerE C Bradley, G P Schechter, M J Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosisE Dmitrovsky, M J Matthews, P A Bunn, et al.
Annals of Internal Medicine|February 1, 1983
The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemiaD W Blayney, E S Jaffe, R I Fisher, et al.
The New England Journal of Medicine|August 4, 1983
Clinical course of retrovirus-associated adult T-cell lymphoma in the United StatesP A Bunn, G P Schechter, E Jaffe, et al.
Annals of Internal Medicine|September 1, 1988
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groupsE A Sausville, J L Eddy, R W Makuch, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
The New England Journal of Medicine|December 28, 1989
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoidesF J Kaye, P A Bunn, S M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-upC F Winkler, E A Sausville, D C Ihde, et al.
Pageof 8